Page last updated: 2024-08-23

sufentanil and Cancer of Gastrointestinal Tract

sufentanil has been researched along with Cancer of Gastrointestinal Tract in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, YJ; Huang, J; Li, TT; Liu, F; Wang, TH; Xiong, LL; Yin, L1
Chen, QH; Hu, Q; Wang, WX; Zhang, XK1

Trials

1 trial(s) available for sufentanil and Cancer of Gastrointestinal Tract

ArticleYear
Evaluation of dexmedetomidine in combination with sufentanil or butorphanol for postoperative analgesia in patients undergoing laparoscopic resection of gastrointestinal tumors: A quasi-experimental trial.
    Medicine, 2016, Volume: 95, Issue:50

    Topics: Adult; Aged; Analgesics, Opioid; Butorphanol; Dexmedetomidine; Drug Therapy, Combination; Female; Gastrointestinal Neoplasms; Humans; Laparoscopy; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Sufentanil; Treatment Outcome

2016

Other Studies

1 other study(ies) available for sufentanil and Cancer of Gastrointestinal Tract

ArticleYear
Analgesic effects of sufentanil in combination with flurbiprofen axetil and dexmedetomidine after open gastrointestinal tumor surgery: a retrospective study.
    BMC anesthesiology, 2022, 04-29, Volume: 22, Issue:1

    Topics: Analgesics; Analgesics, Opioid; Dexmedetomidine; Flurbiprofen; Gastrointestinal Neoplasms; Humans; Metoclopramide; Pain, Postoperative; Retrospective Studies; Sufentanil

2022